ImQuest BioSciences

ImQuest BioSciences is a privately held, revenue-generating contract research organization specializing in preclinical infectious disease and oncology testing. The company operates as a service provider, offering comprehensive in vitro and in vivo evaluation services for small molecules, biologics, antibodies, and vaccines. With decades of collective expertise, it serves a diverse global client portfolio, from large pharma to virtual biotechs, by providing customized assay development and R&D support. Its business model is built on outsourcing and fee-for-service contracts, positioning it as a specialized partner in early-stage drug development.

Suite of customizable preclinical assay services and expertise in virology, microbiology, oncology, and immunology for evaluating novel chemical entities, biologics, and vaccines.

Operates in the competitive preclinical CRO sector, competing with large full-service organizations (e.g., Charles River Laboratories, LabCorp) and other specialized infectious disease CROs. Differentiation is based on deep expertise in virology/microbiology, customized service, and niche focus.